Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × Off-Label Use × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

pembrolizumab 6 Injections 5 tislelizumab 4 senaparib 4 Nivolumab 3 Bevacizumab 3 toripalimab 2 spartalizumab 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 zimberelimab 1 tumor-cells apoptosis factor, human 1 tazemetostat 1 sotorasib 1 sintilimab 1 sacituzumab govitecan 1 rucaparib 1 romiplostim 1 osimertinib 1 olaparib 1 magrolimab 1 enzalutamide 1 cemiplimab 1 cedazuridine 1 binimetinib 1 atezolizumab 1 WW Domain-Containing Oxidoreductase 1 Ultrasonography, Doppler 1 Ultrasonography 1 Technetium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06956248 2025-05-04

IMPACT-INSPIRE

National Cancer Centre, Singapore

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡